Consensus recommendations on mental health issues in Phelan-McDermid syndrome

被引:5
|
作者
van Balkom, Ingrid D. C. [1 ,2 ]
Burdeus-Olavarrieta, Monica [3 ,4 ]
Cooke, Jennifer [5 ]
de Cuba, A. Graciela [1 ]
Turner, Alison [6 ]
Vogels, Annick [8 ]
Maruani, Anna [9 ,10 ]
机构
[1] Lentis Psychiat Inst, Jonx Dept Youth Mental Hlth & Autism, Groningen, Netherlands
[2] Univ Med Ctr Groningen, Rob Giel Res Ctr, Dept Psychiat, Groningen, Netherlands
[3] Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, Dept Child & Adolescent Psychiat, IiSGM,Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[4] Univ Autonoma, Sch Psychol, Madrid, Spain
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Forens & Neurodev Sci Dept, London, England
[6] Phelan McDermid Syndrome Fdn UK, 99 Highgate W Hill, London N6 6NR, England
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[8] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium
[9] Hop Robert Debre, AP HP, Excellence Ctr Autism Spectrum & Neurodev Disorde, Inovand,Child & Adolescent Psychiat Dept, Paris, France
[10] Defiscience, Rare Dis Ctr Intellectual Disabil, CRMR DICR, Paris, France
关键词
Phelan-McDermid syndrome; Mental health; Developmental level; Adaptive functioning; Behaviour; Psychiatric symptoms; DELETION SYNDROME; CATATONIA; DISABILITY; PHENOTYPE; ADULTS;
D O I
10.1016/j.ejmg.2023.104770
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Phelan-McDermid syndrome is a rare genetic condition caused by a deletion encompassing the 22q13.3 region or a pathogenic variant of the gene SHANK3. The clinical presentation is variable, but main characteristics include global developmental delay/intellectual disability (ID), marked speech impairment or delay, along with other features like hypotonia and somatic or psychiatric comorbidities. This publication delineates mental health, developmental and behavioural themes across the lifetime of individuals with PMS as informed by parents/ caregivers, experts, and other key professionals involved in PMS care. We put forward several recommendations based on the available literature concerning mental health and behaviour in PMS. Additionally, this article aims to improve our awareness of the importance of considering developmental level of the individual with PMS when assessing mental health and behavioural issues. Understanding how the discrepancy between developmental level and chronological age may impact concerning behaviours offers insight into the meaning of those behaviours and informs care for individuals with PMS, enabling clinicians to address unmet (mental health) care needs and improve quality of life.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Phelan-McDermid syndrome and cancer predisposition: The value of a karyotype
    McKelvey, Kent D., Jr.
    Trana, Carol J.
    Kelsay, Jill
    Sawyer, Jeffrey
    Clothier, Jeffrey
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (01) : 144 - 145
  • [42] The Role of Lithium in the Management of Altered Mental Status in Phelan-McDermid Syndrome: A Case Report
    Charara, Raghid
    Shapiro-Krew, Anna P.
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S161 - S161
  • [43] Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome
    Gergoudis, Kellie
    Weinberg, Alan
    Templin, Jonathan
    Farmer, Cristan
    Durkin, Alison
    Weissman, Jordana
    Siper, Paige
    Foss-Feig, Jennifer
    Trelles, Maria del Pilar
    Bernstein, Jonathan A.
    Buxbaum, Joseph D.
    Berry-Kravis, Elizabeth
    Powell, Craig M.
    Sahin, Mustafa
    Soorya, Latha
    Thurm, Audrey
    Kolevzon, Alexander
    AUTISM RESEARCH, 2020, 13 (08) : 1383 - 1396
  • [44] A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    J. Fastman
    J. Foss-Feig
    Y. Frank
    D. Halpern
    H. Harony-Nicolas
    C. Layton
    S. Sandin
    P. Siper
    L. Tang
    P. Trelles
    J. Zweifach
    J. D. Buxbaum
    A. Kolevzon
    Molecular Autism, 12
  • [45] Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome
    Ahn, Hyunji
    Seo, Go Hun
    Keum, Changwon
    Heo, Sun Hee
    Kim, Taeho
    Choi, Jeongmin
    Yum, Mi-Sun
    Lee, Beom Hee
    BRAIN & DEVELOPMENT, 2020, 42 (05): : 414 - 417
  • [46] Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
    Wang, A. Ting
    Lim, Teresa
    Jamison, Jesslyn
    Bush, Lauren
    Soorya, Latha V.
    Tavassoli, Teresa
    Siper, Paige M.
    Buxbaum, Joseph D.
    Kolevzon, Alexander
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2016, 8
  • [47] A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
    Fastman, J.
    Foss-Feig, J.
    Frank, Y.
    Halpern, D.
    Harony-Nicolas, H.
    Layton, C.
    Sandin, S.
    Siper, P.
    Tang, L.
    Trelles, P.
    Zweifach, J.
    Buxbaum, J. D.
    Kolevzon, A.
    MOLECULAR AUTISM, 2021, 12 (01)
  • [48] Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome
    Droogmans, Gilles
    Swillen, Ann
    Van Buggenhout, Griet
    MOLECULAR SYNDROMOLOGY, 2020, 10 (06) : 294 - 305
  • [49] Parental perspectives on Phelan-McDermid syndrome: Results of a worldwide survey
    Landlust, Annemiek M.
    Koza, Sylvia A.
    Carbin, Maya
    Walinga, Margreet
    Robert, Sandra
    Cooke, Jennifer
    Vyshka, Klea
    van Balkom, Ingrid D. C.
    van Ravenswaaij-Arts, Conny
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2023, 66 (07)
  • [50] Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
    A. Ting Wang
    Teresa Lim
    Jesslyn Jamison
    Lauren Bush
    Latha V. Soorya
    Teresa Tavassoli
    Paige M. Siper
    Joseph D. Buxbaum
    Alexander Kolevzon
    Journal of Neurodevelopmental Disorders, 2016, 8